Drug recall D-0286-2021
Product
Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631.
Reason for recall
Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium
Lots and codes
Lot C11507A
Recall details
- Recalling firm
- Meitheal Pharmaceuticals Inc, Chicago, IL
- Quantity
- 34,860 vials
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 27, 2021
- Terminated
- October 16, 2023
Related products
- Cisatracurium Besylate – drug information
- NDC 71288-714 Cisatracurium Besylate · Cisatracurium Besylate 20 mg/10mL · Meitheal Pharmaceuticals Inc.
- NDC 71288-712 Cisatracurium Besylate · Cisatracurium Besylate 10 mg/5mL · Meitheal Pharmaceuticals Inc.
- NDC 71288-713 Cisatracurium Besylate · Cisatracurium Besylate 200 mg/20mL · Meitheal Pharmaceuticals Inc.